Glucagon-like peptide-1 (GLP-1) receptor agonists may improve cardiovascular outcomes in the year following TAVI for aortic ...

A team led by metabolism researcher Prof Timo D. Müller at Helmholtz Munich has developed a new approach for treating obesity ...

Orforglipron is a new oral GLP-1 drug that outperforms oral semaglutide in blood sugar control and weight loss while offering ...

This retrospective, single‐center study included all patients aged 18 to 65 years who presented with ACS and underwent ...

Kentucky Derby betting is in full swing. See exclusive Kentucky Derby promo codes for sites like TwinSpires, FanDuel Racing ...

One Steelers undrafted free agent has a more realistic path to the 2026 roster than the rest, and his case starts with ...

Based on extensive research, there is insufficient scientific evidence to support taking an omega-3 supplement daily to ...

Which teams filled a need with a potential star? Which GMs might wind up regretting their decisions down the line?

UCSF research led to the first type 1 diabetes immunotherapy. Now, scientists are using stem cells and Tregs to find a ...

Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. In type 1 diabetes, the ...

As increasing numbers of people with type 1 diabetes live into old age, a large new study has found they face almost three times the risk of developing dementia compared to people without the ...

A new study has found that people with type 1 diabetes are nearly three times as likely to develop dementia as those without diabetes. “We have known that type 2 diabetes is linked to an increased ...